Cairo – Mubasher: Kahira Pharmaceuticals announced that its profit rose by 17.4% in December, 2015, compared to December, 2014.
According to the company’s financial statements, net profit after tax jumped to EGP5.6 million ($722,300), from EGP4.8 million ($619,100).
The company’s production value for the same month also leapt to EGP48.2 million, from EGP37.3 million.
Further, profits during the first quarter ended 30 September, 2015 increased by 6.7%.
